BSE Live
Dec 30, 16:01Prev. Close
1136.30
Open Price
1136.30
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
| Key Financial Ratios of Kwality Pharmaceuticals (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 38.36 | 22.76 | 18.16 | 115.64 | 14.60 | |
| Diluted EPS (Rs.) | 38.36 | 22.76 | 18.16 | 115.64 | 14.60 | |
| Cash EPS (Rs.) | 55.99 | 41.61 | 33.00 | 125.89 | 20.61 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 253.70 | 213.74 | 191.08 | 172.50 | 56.91 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 254.47 | 214.51 | 191.85 | 173.27 | 57.68 | |
| Revenue from Operations/Share (Rs.) | 356.78 | 296.03 | 241.93 | 439.65 | 252.51 | |
| PBDIT/Share (Rs.) | 79.32 | 65.67 | 60.79 | 168.82 | 29.33 | |
| PBIT/Share (Rs.) | 61.70 | 46.82 | 46.38 | 158.52 | 23.08 | |
| PBT/Share (Rs.) | 52.18 | 29.97 | 24.65 | 155.71 | 20.50 | |
| Net Profit/Share (Rs.) | 38.36 | 22.76 | 18.58 | 115.59 | 14.35 | |
| NP After MI And SOA / Share (Rs.) | 38.40 | 22.93 | 18.67 | 115.64 | 14.60 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 22.23 | 22.18 | 25.12 | 38.39 | 11.61 | |
| PBIT Margin (%) | 17.29 | 15.81 | 19.16 | 36.05 | 9.13 | |
| PBT Margin (%) | 14.62 | 10.12 | 10.18 | 35.41 | 8.11 | |
| Net Profit Margin (%) | 10.75 | 7.68 | 7.68 | 26.29 | 5.68 | |
| NP After MI And SOA Margin (%) | 10.76 | 7.74 | 7.71 | 26.30 | 5.78 | |
| Return on Networth/Equity (%) | 15.13 | 10.65 | 9.69 | 66.53 | 25.09 | |
| Return on Capital Employed (%) | 23.04 | 20.04 | 21.13 | 78.21 | 27.21 | |
| Return on Assets (%) | 8.90 | 6.03 | 5.47 | 35.23 | 9.10 | |
| Total Debt/Equity (X) | 0.43 | 0.44 | 0.45 | 0.24 | 0.58 | |
| Asset Turnover Ratio (%) | 0.88 | 0.82 | 0.72 | 1.79 | 1.73 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.67 | 1.60 | 1.65 | 1.75 | 1.35 | |
| Quick Ratio (X) | 1.18 | 1.08 | 0.96 | 1.34 | 1.13 | |
| Inventory Turnover Ratio (X) | 4.57 | 1.87 | 1.62 | 5.64 | 8.31 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Coverage Ratios | ||||||
| Interest Coverage Ratios (%) | 8.33 | 6.56 | 10.48 | 60.05 | 11.39 | |
| Interest Coverage Ratios (Post Tax) (%) | 8.33 | 6.56 | 10.48 | 60.05 | 11.39 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 997.78 | 515.35 | 400.57 | 630.81 | 85.72 | |
| EV/Net Operating Revenue (X) | 2.70 | 1.68 | 1.60 | 1.38 | 0.33 | |
| EV/EBITDA (X) | 12.12 | 7.56 | 6.35 | 3.60 | 2.82 | |
| MarketCap/Net Operating Revenue (X) | 2.44 | 1.38 | 1.27 | 1.32 | 0.22 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | 3.43 | 1.90 | 1.60 | 3.34 | 0.96 | |
| Price/Net Operating Revenue | 2.44 | 1.38 | 1.27 | 1.32 | 0.22 | |
| Earnings Yield | 0.04 | 0.06 | 0.06 | 0.20 | 0.26 |
04.12.2025
Kwality Pharmac Consolidated September 2025 Net Sales at Rs 111.05 crore, up 23.34% Y-o-Y
27.11.2025
Kwality Pharmac Standalone September 2025 Net Sales at Rs 111.31 crore, up 23.63% Y-o-Y
08.09.2025
Kwality Pharmac Standalone June 2025 Net Sales at Rs 111.48 crore, up 39.21% Y-o-Y
20.05.2025
Kwality Pharmac Consolidated March 2025 Net Sales at Rs 115.68 crore, up 25.77% Y-o-Y
04.12.2025
Kwality Pharmac Consolidated September 2025 Net Sales at Rs 111.05 crore, up 23.34% Y-o-Y
27.11.2025
Kwality Pharmac Standalone September 2025 Net Sales at Rs 111.31 crore, up 23.63% Y-o-Y
08.09.2025
Kwality Pharmac Standalone June 2025 Net Sales at Rs 111.48 crore, up 39.21% Y-o-Y
20.05.2025
Kwality Pharmac Consolidated March 2025 Net Sales at Rs 115.68 crore, up 25.77% Y-o-Y